PB Trademark

Trademark Overview

On Friday, March 24, 2023, a trademark application was filed for PB with the United States Patent and Trademark Office. The USPTO has given the PB trademark a serial number of 97980002. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Tuesday, June 3, 2025. This trademark is owned by Parallel Biosystems, Inc.. The PB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical scientific research testing, research and development services in the fields of immune organoids, immune system modeling, antibodies, pharmaceuticals, biologics, immunotherapies, and cell therapies; Drug discovery services; Biotechnology research and development services, namely, providing screening and analysis of immune responses, antibodies, human cells, and pharmaceutical and biologic therapies
pb

General Information

Serial Number97980002
Word MarkPB
Filing DateFriday, March 24, 2023
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateTuesday, June 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, February 27, 2024

Trademark Statements

Description of MarkThe mark consists of the letters p and b in lower case displayed as a loop.
Pseudo MarkPARALLEL BIO
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical scientific research testing, research and development services in the fields of immune organoids, immune system modeling, antibodies, pharmaceuticals, biologics, immunotherapies, and cell therapies; Drug discovery services; Biotechnology research and development services, namely, providing screening and analysis of immune responses, antibodies, human cells, and pharmaceutical and biologic therapies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, April 16, 2023
Primary Code042
First Use Anywhere DateFriday, April 30, 2021
First Use In Commerce DateFriday, April 30, 2021

Trademark Owner History

Party NameParallel Biosystems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameParallel Biosystems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, March 28, 2023NEW APPLICATION ENTERED
Sunday, April 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 19, 2023ASSIGNED TO EXAMINER
Friday, December 22, 2023NON-FINAL ACTION WRITTEN
Friday, December 22, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 22, 2023NON-FINAL ACTION E-MAILED
Sunday, January 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, January 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 24, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 27, 2024PUBLISHED FOR OPPOSITION
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 23, 2024DIVISIONAL REQUEST RECEIVED
Wednesday, October 23, 2024SOU EXTENSION 2 FILED
Wednesday, October 23, 2024USE AMENDMENT FILED
Wednesday, October 23, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 23, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, October 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 23, 2024SOU EXTENSION 1 FILED
Wednesday, October 23, 2024SOU EXTENSION 1 GRANTED
Wednesday, October 23, 2024TEAS REQUEST TO DIVIDE RECEIVED
Thursday, April 17, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 21, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, April 21, 2025SOU EXTENSION 2 GRANTED
Monday, April 21, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 21, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 21, 2025DIVISIONAL PROCESSING COMPLETE
Tuesday, June 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 3, 2025SU - NON-FINAL ACTION - WRITTEN
Tuesday, June 3, 2025NON-FINAL ACTION E-MAILED
Wednesday, June 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

services research immune antibodies development therapies screening providing biotechnology namely